Literature DB >> 24023605

The challenge of corporeity: fictionalising the emotional body.

Ioana Balgradean.   

Abstract

Geoffrey Chaucer's Troilus and Criseyde (ca. 1380) writes emotions as corporeal events unfolding as specific sensorimotor, cognitive actions, which, in particular cases, may develop pathological offshoots. This paper explores the unstable, organic quality of the emotional phenomenon, and its fluid formal potential. Indeed, while emotion resists definitive categorical and conceptual containment, it must be named, made sense of, thus signalling the power of corporeity to shape language and thought. Crucially, this allows us to measure the importance of cognitive and epistemological modes we activate with the purpose of grasping emotion as irreducible aspect of the human. In this sense, poetic expression emerges as a necessity: through continuous actualisation of its formal plasticity, literature enables the provisory encoding and circulation of emotional phenomena, by exploring the interface between a perceiving body and its phenomenal environment, while allowing for the emergence of new modes of thinking. I proceed to a transepistemic examination of the text in question, by means of historically-informed conceptual tools, beyond the inappropriate categorical dissonances between body and mind, affect and intellect, philosophy, literature, and science.

Entities:  

Keywords:  cognition; corporeity; emotion; literature; sensorimotricity

Year:  2013        PMID: 24023605      PMCID: PMC3749769     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  2 in total

1.  Conscious emotional experience emerges as a function of multilevel, appraisal-driven response synchronization.

Authors:  Didier Grandjean; David Sander; Klaus R Scherer
Journal:  Conscious Cogn       Date:  2008-04-29

2.  Emotions are emergent processes: they require a dynamic computational architecture.

Authors:  Klaus R Scherer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-12-12       Impact factor: 6.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.